MedCity News October 7, 2021
Graphwear recently raised $20.5 million, which it plans to use to develop a CGM that uses nanotechnology to measure blood glucose levels.
Graphwear co-founders Saurabh Radhakrishnan and Rajatesh Gudibande want to make CGMs that use nanotechnology to measure blood glucose levels. Photo credit: GraphwearIn the U.S., roughly half of patients with Type 1 diabetes use continuous glucose monitors (CGMs), and worldwide, the number is much lower. A startup hopes to change that by making CGMs more accessible using a needle-free version of the device.
San Francisco-based Graphwear recently raised $20.5 million in funding led by venture capital firm Mayfield. It plans to use the funds to further develop its nanotech-based CGM device, grow its team and conduct more trials...
Today's Sponsors
Today's Sponsor